125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab

125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 27; p. ix37
Main Authors: Veenstra, C., Ellegard, S., Perez-Tenorio, G., FagerstrOm, V., Garsjo, J., Briedis, K., Sundqvist, M., MalmstrOm, A., Wingren, S., Stai, O.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-12-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/S0923-7534(21)00284-2